FDA Inspection 1333016 — Nippon Sanso Matheson, Inc.

Nippon Sanso Matheson, Inc. — FEI 2521876

The FDA completed an inspection of Nippon Sanso Matheson, Inc. on Jul 29, 2026 in Saint Marys, PA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI)
End Date
Jul 29, 2026
Fiscal Year
2026
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Saint Marys, PA (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.